Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis Portfolio News / By Karina Tin March 25, 2020
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update Portfolio News / By Karina Tin March 23, 2021
RAPT Therapeutics Completes Enrollment in Phase 1b Trial of RPT193 in Atopic Dematitis Portfolio News / By Karina Tin March 22, 2021
Carmot Therapeutics expands leadership team with appointment of Manu Chakravarthy, MD, PhD as Chief Medical Officer and Executive Vice President of R&D Portfolio News / By Karina Tin March 16, 2021
Nurix Therapeutics Announces Collaboration for the Discovery of Novel Drugs to Treat Pediatric Cancers Portfolio News / By Karina Tin March 16, 2021
RAPT Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results Portfolio News / By Karina Tin March 11, 2021
Nurix Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Portfolio News / By Karina Tin March 9, 2021
NGM Bio Provides Business Highlights and Reports Fourth Quarter and Full Year 2020 Financial Results Portfolio News / By Karina Tin March 4, 2021
Revolution Medicines Reports Fourth Quarter and Year-End 2020 Financial Results and Update on Corporate Progress Portfolio News / By Karina Tin March 2, 2021
NGM Bio Initiates Expansion of Ongoing Phase 1b Proof-of-Concept Study of NGM120 in Patients with Metastatic Pancreatic Cancer Portfolio News / By Karina Tin March 2, 2021
